News

After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...
Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than ...
Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...
A buyer had actually already been found for 23andme, but a competitor is not giving up: The ex-boss of the company may have ...
Me (OTC:MEHCQ) faces a second auction after a $305M bid challenges Regeneron's (REGN) initial bid for its assets. Read more ...
Shares of PVH Corp. fell after hours on Wednesday after the Calvin Klein and Tommy Hilfiger parent cut its full-year profit outlook, citing the impact of tariffs on shipments heading into the U.S.
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
Bankrupt genetic testing company 23andMe told a U.S. bankruptcy judge on Wednesday that it wants to re-open bidding on its ...
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...
Regeneron Pharma stock has been in a persistent downtrend for over 280 days. Here's why you should avoid REGN.
The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...